Twist Bioscience Corp (TWST)
41.62
+0.51
(+1.24%)
USD |
NASDAQ |
Nov 21, 16:00
41.62
0.00 (0.00%)
After-Hours: 20:00
Twist Bioscience Profit Margin (Quarterly): -40.91% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -40.91% |
June 30, 2024 | -105.0% |
March 31, 2024 | -60.41% |
December 31, 2023 | -60.15% |
September 30, 2023 | -69.08% |
June 30, 2023 | -90.05% |
March 31, 2023 | -98.30% |
December 31, 2022 | -77.10% |
September 30, 2022 | -89.20% |
June 30, 2022 | -107.8% |
March 31, 2022 | -126.1% |
December 31, 2021 | -108.4% |
September 30, 2021 | -108.7% |
June 30, 2021 | -114.3% |
March 31, 2021 | -121.5% |
Date | Value |
---|---|
December 31, 2020 | -116.8% |
September 30, 2020 | -74.98% |
June 30, 2020 | -133.0% |
March 31, 2020 | -164.6% |
December 31, 2019 | -324.2% |
September 30, 2019 | -198.1% |
June 30, 2019 | -205.3% |
March 31, 2019 | -191.3% |
December 31, 2018 | -197.0% |
September 30, 2018 | -235.5% |
June 30, 2018 | -269.4% |
March 31, 2018 | -273.6% |
December 31, 2017 | -392.7% |
September 30, 2017 | -490.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-324.2%
Minimum
Dec 2019
-40.91%
Maximum
Sep 2024
-109.5%
Average
-106.4%
Median
Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | -18.58% |
InfuSystems Holdings Inc | 5.12% |
Xtant Medical Holdings Inc | -17.98% |
Catheter Precision Inc | -4.29K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -38.12% |
Return on Assets | -30.12% |
Return on Invested Capital | -38.12% |
Gross Profit Margin (Quarterly) | 45.13% |
Operating Margin (Quarterly) | -42.55% |
Return on Net Operating Assets | -54.19% |